Michael J. Welsh
36Patents
10h-index
42Co-inventors
75Inventor score
Filing activity: Jul 26, 1988 → Oct 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5935936A | Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules | Chemistry; Metallurgy | 55 | Expired |
| US9254295B2 | Tomatidine, analogs thereof, compositions comprising same, and uses for same | Chemistry; Metallurgy | 26 | Active |
| US6716819B2 | Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections | Human Necessities | 21 | Expired |
| US5234922A | Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea | Human Necessities | 21 | Expired |
| US7446089B2 | Methods of inhibiting and treating bacterial biofilms by metal chelators | Human Necessities | 18 | Expired |
| US5639661A | Genes and proteins for treating cystic fibrosis | Human Necessities | 17 | Expired |
| US9295664B2 | Methods for lowering blood glucose | Physics | 16 | Active |
| US5892018A | DNA sequences encoding a brain sodium channel protein | Chemistry; Metallurgy | 13 | Expired |
| US5962429A | Complexes of adenovirus with cationic molecules | Chemistry; Metallurgy | 12 | Expired |
| US5958893A | Genes and proteins for treating cystic fibrosis | Human Necessities | 10 | Expired |
| US7989675B2 | Method of identifying compounds using a transgenic pig model of cystic fibrosis | Human Necessities | 8 | Active |
| US7071293B1 | Alpha helical peptides with broad spectrum antimicrobial activity that are insensitive to salt | Human Necessities | 8 | Expired |
| US5958907A | Pharmaceutical compositions and uses of inorganic pyrophosphates | Human Necessities | 7 | Expired |
| US4841693A | Particulate material storage structure | Mechanical Engineering; Lighting; Heating | 6 | Expired |
| US5686114A | Uses of inorganic pyrophosphates | Human Necessities | 6 | Expired |
| US10137136B2 | Methods for inhibiting muscle atrophy | Physics | 6 | Active |
| US9856204B2 | Methods for inhibiting muscle atrophy | Chemistry; Metallurgy | 5 | Active |
| US6635432B1 | Peptide potentiation of acid-sensory ion channel in pain | Chemistry; Metallurgy | 5 | Expired |
| US6086870A | Co-precipitates of adenovirus with metal salts | Chemistry; Metallurgy | 4 | Expired |
| US7407801B2 | Truncated CMV promoters and vectors containing same | Chemistry; Metallurgy | 3 | Expired |
| US8618352B2 | Transgenic porcine models of cystic fibrosis | Human Necessities | 3 | Active |
| US8343911B2 | Methods of inhibiting and treating bacterial biofilms by metal chelators | Human Necessities | 2 | Active |
| US8912386B2 | Transgenic pig model of cystic fibrosis | Human Necessities | 2 | Active |
| US7339046B2 | CFTR with a partially deleted R domain and uses thereof | Chemistry; Metallurgy | 2 | Expired |
| US7132405B2 | Targeting vector to the urokinase plasminogen activator receptor | Chemistry; Metallurgy | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.